A phase I dose-escalation study of PEP02 (irinotecan liposome injection) in combination with 5-fluorouracil and leucovorin in advanced solid tumors

Por Chiang, Nai-Jung, Chao, Tsu-Yi, Hsieh, Ruey-Kuen, Wang, Cheng-Hsu, Wang, Yi-Wen, Yeh, C. Grace, Chen, Li-Tzong
Publicado no BMC Cancer (2016)

PEPCOL: a GERCOR randomized phase II study of nanoliposomal irinotecan PEP02 (MM‐398) or irinotecan with leucovorin/5‐fluorouracil as second‐line therapy in metastatic colorectal c...

Por Chibaudel, Benoist, Maindrault‐Gœbel, Frédérique, Bachet, Jean‐Baptiste, Louvet, Christophe, Khalil, Ahmed, Dupuis, Olivier, Hammel, Pascal, Garcia, Marie‐Line, Bennamoun, Mostefa, Brusquant, David, Tournigand, Christophe, André, Thierry, Arbaud, Claire, Larsen, Annette K, Wang, Yi‐Wen, Yeh, C. Grace, Bonnetain, Franck, de Gramont, Aimery
Publicado no Cancer Med (2016)